ImpriMed, Inc. · 8 hours ago
Regional Sales Manager (Veterinary Oncology)
Maximize your interview chances
Artificial Intelligence (AI)Biotechnology
Insider Connection @ImpriMed, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
• Territory targeting and planning; pipeline and account development to meet revenue goals.
• Work with sense of urgency and an entrepreneurial spirit in building the business.
• Deliver technical and functional presentations to clients including Veterinary Oncologists, Veterinary Nurses and Technicians, Service Line Directors, Practice Managers, and C-level Administrators.
• Work closely with the Marketing team to address barriers to adoption and collaboratively develop tactics to overcome.
• As part of a team accurately forecast monthly, quarterly, and yearly revenues and ensure consistent utilization in new centers with a patient-centric approach.
• Present detailed reports to Management regarding sales activities and success rates regularly.
• Road warrior. Travel within the territory required, up to 80%
· ImpriMed is seeking a commercial sales professional to join its team as the Regional Sales Manager, California, to drive the organization’s evolution from development stage to commercial product use. This demanding and challenging role requires robust and refined skills in selling, listening, and adaptability in a clinical setting at specialty veterinary oncology hospitals or clinics. The Regional Sales Manager will own and deliver the sales execution to drive utilization in the commercial sales organization, collaborating with the commercial team and strategic partners. This position reports to the Vice President of Commercial Operations.
· The primary focus of the role is the execution of the sales strategy. This includes translating the overall strategy into tactical sales growth to ensure outcomes and financial goals are achieved. The role will be dynamic and require strong team collaboration. The role requires an individual to strategically target new centers and ensure a positive customer experience in a performance-based culture. A successful candidate will draw on their experience of creating new markets with disruptive technology, with a demonstrated track record of collaborating with strategic partners.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
5+ years in oncology or veterinary oncology, veterinary medical device, or diagnostic laboratory sales to specialty doctors (oncologists)
Demonstrated experience and a strong record of success within a startup environment
Comfortable with complex sales and multiple stakeholders
Proven track record of developing commercial strategies for novel technologies
Comfortable in a team environment; the multi-faceted nature of the opportunity requires strong collaboration in a fast-paced culture with an ability to pivot through experience
Experience collaborating with strategic partners to find a way for both parties to win
Analytical thinker who possesses exceptional communication and people skills
Preferred
Experience selling products in veterinary oncology or oncology space strongly preferred
Experience launching new product categories 'from scratch' at venture-backed companies is highly desired
A thorough understanding of complex selling in business practices and an in-depth understanding of pioneering medical paradigm changes is highly desired
Early-stage startup experience with strong cross-functional skills is desirable
The ability to build relationships with KOLs and clinically run cases with an 'all-hands-on-deck' mentality for tactical sales execution
Company
ImpriMed, Inc.
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases.
Funding
Current Stage
Early StageTotal Funding
$34.73MKey Investors
SBVAMayo Clinic PlatformHG Initiative
2023-11-10Series A· $23M
2022-08-10Seed· Undisclosed
2021-04-13Seed· $7.7M
Recent News
Company data provided by crunchbase